Peter Nickerson

20.9k total citations · 2 hit papers
202 papers, 10.6k citations indexed

About

Peter Nickerson is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Peter Nickerson has authored 202 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Transplantation, 93 papers in Surgery and 39 papers in Immunology. Recurrent topics in Peter Nickerson's work include Renal Transplantation Outcomes and Treatments (124 papers), Organ Transplantation Techniques and Outcomes (65 papers) and Transplantation: Methods and Outcomes (30 papers). Peter Nickerson is often cited by papers focused on Renal Transplantation Outcomes and Treatments (124 papers), Organ Transplantation Techniques and Outcomes (65 papers) and Transplantation: Methods and Outcomes (30 papers). Peter Nickerson collaborates with scholars based in Canada, United States and Switzerland. Peter Nickerson's co-authors include David N. Rush, Chris Wiebe, Julie Ho, Martin Karpinski, Ian W. Gibson, Terry B. Strom, Patricia E. Birk, John Jeffery, Leroy Storsley and Aviva Goldberg and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Peter Nickerson

196 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

2012 752 citations Chris Wiebe, Ian W. Gibson et al. American Journal of Transplantation profile →
Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody

2015 266 citations Chris Wiebe, Ian W. Gibson et al. American Journal of Transplantation profile →

Peers

Countries citing papers authored by Peter Nickerson

Since Specialization

Citations

This map shows the geographic impact of Peter Nickerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Nickerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Nickerson more than expected).

Fields of papers citing papers by Peter Nickerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Nickerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Nickerson. The network helps show where Peter Nickerson may publish in the future.

Co-authorship network of co-authors of Peter Nickerson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Nickerson. A scholar is included among the top collaborators of Peter Nickerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Nickerson. Peter Nickerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HLA-DQ de novo donor-specific antibody development and its effect on renal allograft survival 2024 ·Human Immunology ·Emmett Tsz Yeung Wong, Robert Balshaw, Ian W. Gibson, Julie Ho, (unknown), Martin Karpinski, Aaron Trachtenberg, Denise Pochinco, Aviva Goldberg, Patricia E. Birk, Maury Pinsk, David N. Rush, Peter Nickerson, Chris Wiebe	0
2	Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients 2024 ·Clinical Transplantation ·(unknown), Chris Wiebe, Robert Balshaw, Jared Bullard, Ian W. Gibson, Aaron Trachtenberg, James Shaw, (unknown), Martin Karpinski, Aviva Goldberg, Patricia E. Birk, Maury Pinsk, David N. Rush, Peter Nickerson, Julie Ho	5
3	A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression 2023 ·American Journal of Transplantation ·Chris Wiebe, Robert Balshaw, Ian W. Gibson, Julie Ho, (unknown), Martin Karpinski, Aaron Trachtenberg, Denise Pochinco, Aviva Goldberg, Patricia E. Birk, Maury Pinsk, David N. Rush, Peter Nickerson	9
4	Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document 2023 ·American Journal of Transplantation ·Carmen Lefaucheur, Kévin Louis, Anna B. Morris, Jean‐Luc Taupin, Peter Nickerson, Anat R. Tambur, Howard M. Gebel, Elaine F. Reed, Jon Kobashigawa, Anil Chandraker, Patricia P. Chang, Monica Colvin, Ramsey R. Hachem, Laurie D. Snyder, Stuart C. Sweet, Deborah J. Levine, Stuart J. Knechtle, Jacqueline G. O’Leary, Joshua Levitsky	38
5	Effectiveness of T cell–mediated rejection therapy: A systematic review and meta-analysis 2021 ·American Journal of Transplantation ·Julie Ho, George N. Okoli, Rasheda Rabbani, Olt Lam, (unknown), Nicole Askin, (unknown), Aaron Trachtenberg, Chris Wiebe, Peter Nickerson, Ahmed M Abou-Setta	35
6	Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report 2020 ·American Journal of Transplantation ·Roslyn B. Mannon, Randall E. Morris, Michaël Abécassis, David A. Axelrod, (unknown), Gary S. Friedman, Peter S. Heeger, Krista L. Lentine, Alexandre Loupy, Barbara Murphy, Peter Nickerson, Minnie Sarwal, Inish O’Doherty, (unknown), (unknown)	12
7	Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report 2020 ·American Journal of Transplantation ·Anat R. Tambur, Patricia Campbell, Anita S. Chong, Sandy Feng, Mandy L. Ford, Howard M. Gebel, Ronald G. Gill, Garnett Kelsoe, Vasilis Kosmoliaptsis, Roslyn B. Mannon, Michael Mengel, Elaine F. Reed, Nicole M. Valenzuela, Chris Wiebe, E. Dijke, Harold C. Sullivan, Peter Nickerson	80
8	Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell–mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study 2020 ·Pediatric Transplantation ·(unknown), Ian W. Gibson, Julie Ho, Peter Nickerson, David N. Rush, Atul Sharma, David S. Wishart, Tom Blydt‐Hansen	8
9	Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation 2020 ·Clinical Proteomics ·(unknown), Brice Korkmaz, (unknown), Adam Lesner, (unknown), Julie Ho, Peter Nickerson, John A. Wilkins	3
10	Kidney Paired Donation Protocol for Participating Donors 2014 2015 ·Transplantation ·Robert Richardson, Maureen T. Connelly, Christine Dipchand, Amit X. Garg, Anand Ghanekar, Isabelle Houde, Olwyn Johnston, Rahul Mainra, (unknown), Thomas Mueller, Peter Nickerson, (unknown), Leroy Storsley, Kathryn Tinckam, Linda Wright, Serdar Yılmaz, David Landsberg	36
11	Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury 2015 ·Transplantation ·Julie Ho, David N. Rush, Oleg V. Krokhin, Mihaela Antonovici, Ang Gao, (unknown), Chris Wiebe, Brett Hiebert, Claudio Rigatto, Ian W. Gibson, John A. Wilkins, Peter Nickerson	22
12	Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes 2013 ·American Journal of Transplantation ·Chris Wiebe, Denise Pochinco, Tom Blydt‐Hansen, Julie Ho, Patricia E. Birk, Martin Karpinski, Aviva Goldberg, Leroy Storsley, Ian W. Gibson, David N. Rush, Peter Nickerson	269
13	Comprehensive Assessment and Standardization of Solid Phase Multiplex-Bead Arrays for the Detection of Antibodies to HLA 2013 ·American Journal of Transplantation ·Elaine F. Reed, P. Nagesh Rao, Zuo‐Feng Zhang, Howard M. Gebel, Robert A. Bray, Indira Guleria, John G. Lunz, Thalachallour Mohanakumar, Peter Nickerson, Anat R. Tambur, Adriana Zeevi, Peter S. Heeger, David Gjertson	173
14	Killer Immunoglobulin-Like Receptor (KIR) Centromeric-AA Haplotype Is Associated with Ethnicity and Tuberculosis Disease in a Canadian First Nations Cohort 2013 ·PLoS ONE ·(unknown), Linda Larcombe, Pamela Orr, Peter Nickerson, Joyce Wolfe, Meenu K. Sharma	13
15	Two cases of platelet transfusion refractoriness associated with anti‐CD36 2010 ·Transfusion ·C. Saw, (unknown), Brian R. Curtis, Shayna Zelcer, (unknown), Donna L. Forrest, Peter Nickerson, Tanya Petraszko, Mindy Goldman	16
16	Functional Gene Polymorphisms in Canadian Aboriginal Populations with High Rates of Tuberculosis 2008 ·The Journal of Infectious Diseases ·Linda Larcombe, Pamela Orr, (unknown), (unknown), (unknown), (unknown), (unknown), Bruce Martin, Peter Nickerson	66
17	The Role of Cytokine Gene Polymorphisms in Determining Disease Susceptibility and Phenotype in Inflammatory Bowel Disease 2005 ·The American Journal of Gastroenterology ·(unknown), Peter Nickerson, Çharles N. Bernstein	77
18	Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs. Risk 2003 ·American Journal of Transplantation ·Howard M. Gebel, Robert A. Bray, Peter Nickerson	269
19	Subclinical rejection--a potential surrogate marker for chronic rejection--may be diagnosed by protocol biopsy or urine spectroscopy. 2000 ·PubMed ·David N. Rush, Ray Somorjai, Roxanne Deslauriers, (unknown), John Jeffery, Peter Nickerson	55
20	Cytokines and the Th1/Th2 paradigm in transplantation 1994 ·Current Opinion in Immunology ·Peter Nickerson, Wolfgang Steurer, Jürg Steiger, (unknown), Alan W. Steele, Terry B. Strom	210

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact